Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Cardiovasc Res
    January 2024
  1. MASSON D, Leleu D, Farnier M, Chague F, et al
    Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction.
    Cardiovasc Res. 2024 Jan 9:cvae007. doi: 10.1093.
    >> Share

    December 2023
  2. KRALER S, Balbi C, Vdovenko D, Lapikova-Bryhinska T, et al
    Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans.
    Cardiovasc Res. 2023;119:2729-2742.
    >> Share

  3. WANG L, Feng J, Feng X, Meng D, et al
    Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2023;119:2638-2652.
    >> Share

    November 2023
  4. TSAI TY, Serruys PW
    Complete revascularization for acute coronary syndrome, one step at a time.
    Cardiovasc Res. 2023;119:e152-e154.
    >> Share

  5. WANG X, Gaur M, Mounzih K, Rodriguez HJ, et al
    Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades.
    Cardiovasc Res. 2023;119:2536-2549.
    >> Share

  6. CORRADI F, Masini G, Bucciarelli T, De Caterina R, et al
    Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives.
    Cardiovasc Res. 2023;119:2405-2420.
    >> Share

  7. BECHMANN LE, Emanuelsson F, Nordestgaard BG, Benn M, et al
    Genetic variation in solute carrier family 5 member 2 mimicking sodium-glucose co-transporter 2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose.
    Cardiovasc Res. 2023;119:2482-2493.
    >> Share

  8. LI Z, Dai R, Chen M, Huang L, et al
    p55gamma degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning.
    Cardiovasc Res. 2023;119:2421-2440.
    >> Share

    October 2023
  9. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    >> Share

  10. RUSIECKA OM, Molica F, Nielsen MS, Tollance A, et al
    Mitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury.
    Cardiovasc Res. 2023;119:2342-2354.
    >> Share

    September 2023
  11. FRANGOGIANNIS NG
    Targeting Galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy.
    Cardiovasc Res. 2023 Sep 29:cvad156. doi: 10.1093.
    >> Share

  12. NOGAL A, Alkis T, Lee Y, Kifer D, et al
    Predictive metabolites for incident myocardial infarction: a two-step meta-analysis of individual patient data from six cohorts comprising 7,897 individuals from the the COnsortium of METabolomic Studies.
    Cardiovasc Res. 2023 Sep 14:cvad147. doi: 10.1093.
    >> Share

  13. RUDER AV, Wetzels SMW, Temmerman L, Biessen EAL, et al
    Monocyte heterogeneity in cardiovascular disease.
    Cardiovasc Res. 2023;119:2033-2045.
    >> Share

    July 2023
  14. MARTIN TP, MacDonald EA, Bradley A, Watson H, et al
    RNA interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.
    Cardiovasc Res. 2023 Jul 11:cvad107. doi: 10.1093.
    >> Share

  15. DAVIDSSON P, Eketjall S, Eriksson N, Walentinsson A, et al
    Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.
    Cardiovasc Res. 2023;119:1596-1605.
    >> Share

    June 2023
  16. CHUNG B, Wang Y, Thiel M, Rostami F, et al
    Preemptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction.
    Cardiovasc Res. 2023 Jun 14:cvad092. doi: 10.1093.
    >> Share

  17. XU H, Zheng J, Zhao X, Zhou Q, et al
    Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study.
    Cardiovasc Res. 2023;119:1352-1360.
    >> Share

  18. SAYOUR NV, Brenner GB, Makkos A, Kiss B, et al
    Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study.
    Cardiovasc Res. 2023;119:1336-1351.
    >> Share

  19. ZHAO J, Zhang Q, Cheng W, Dai Q, et al
    Heart-gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion.
    Cardiovasc Res. 2023;119:1390-1402.
    >> Share

  20. BASSUK SS, Manson JE
    Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence.
    Cardiovasc Res. 2023;119:1297-1309.
    >> Share

    May 2023
  21. LEZOUALC'H F, Badimon L, Baker H, Bernard M, et al
    Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality.
    Cardiovasc Res. 2023;119:1130-1145.
    >> Share

  22. LOU X, Tang Y, Ye L, Pretorius D, et al
    Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Cardiovasc Res. 2023;119:1062-1076.
    >> Share

  23. HARTMAN EMJ, De Nisco G, Kok AM, Tomaniak M, et al
    Wall shear stress-related plaque growth of lipid-rich plaques in human coronary arteries: an near-infrared spectroscopy and optical coherence tomography study.
    Cardiovasc Res. 2023;119:1021-1029.
    >> Share

  24. LUO J, Noordam R, Jukema JW, van Dijk KW, et al
    Low leukocyte mitochondrial DNA abundance drives atherosclerotic cardiovascular diseases: a cohort and Mendelian randomization study.
    Cardiovasc Res. 2023;119:998-1007.
    >> Share

  25. NICOLAS J, Pivato CA, Chiarito M, Beerkens F, et al
    Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.
    Cardiovasc Res. 2023;119:631-646.
    >> Share

  26. DONG M, Chen D, Zhu Y, Yang S, et al
    Impaired regulation of MMP2/16-MLCK3 by miR-146a-5p increased susceptibility to myocardial ischaemic injury in aging mice.
    Cardiovasc Res. 2023;119:786-801.
    >> Share

    March 2023
  27. SEMENZA GL
    Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment.
    Cardiovasc Res. 2023;119:371-380.
    >> Share

  28. WOOD A, Antonopoulos A, Chuaiphichai S, Kyriakou T, et al
    PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
    Cardiovasc Res. 2023;119:599-610.
    >> Share

  29. KLEINBONGARD P, Lieder H, Skyschally A, Heusch G, et al
    No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Gottingen minipigs.
    Cardiovasc Res. 2023;119:561-570.
    >> Share

  30. LI Z, Solomonidis EG, Berkeley B, Tang MNH, et al
    Multi-species meta-analysis identifies transcriptional signatures associated with cardiac endothelial responses in the ischaemic heart.
    Cardiovasc Res. 2023;119:136-154.
    >> Share

  31. HEISS C, Rodriguez-Mateos A, Bapir M, Skene SS, et al
    Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health.
    Cardiovasc Res. 2023;119:283-293.
    >> Share

  32. TUFARO V, Serruys PW, Raber L, Bennett MR, et al
    Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications.
    Cardiovasc Res. 2023;119:121-135.
    >> Share

  33. PARKSOOK WW, Williams GH
    Aldosterone and cardiovascular diseases.
    Cardiovasc Res. 2023;119:28-44.
    >> Share

  34. DAVIDSON SM, Boulanger CM, Aikawa E, Badimon L, et al
    Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.
    Cardiovasc Res. 2023;119:45-63.
    >> Share

  35. AKBAR N, Braithwaite AT, Corr EM, Koelwyn GJ, et al
    Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles.
    Cardiovasc Res. 2023;119:236-251.
    >> Share

    January 2023
  36. MOLITOR M, Jimenez MTB, Hahad O, Witzler C, et al
    Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction.
    Cardiovasc Res. 2023 Jan 26:cvad021. doi: 10.1093.
    >> Share

  37. AMBROSINI S, Montecucco F, Kolijn D, Pedicino D, et al
    Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study.
    Cardiovasc Res. 2023;118:3374-3385.
    >> Share

    December 2022
  38. CANONICO F, Pedicino D, Severino A, Vinci R, et al
    GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation.
    Cardiovasc Res. 2022 Dec 13:cvac184. doi: 10.1093.
    >> Share

    November 2022
  39. KROETSCH JT, Lidington D, Alibhai FJ, Reitz CJ, et al
    Disrupting circadian control of peripheral myogenic reactivity mitigates cardiac injury following myocardial infarction.
    Cardiovasc Res. 2022 Nov 22:cvac174. doi: 10.1093.
    >> Share

  40. BERGAMI M, Cenko E, Yoon J, Mendieta G, et al
    Statins for primary prevention among elderly men and women.
    Cardiovasc Res. 2022;118:3000-3009.
    >> Share

    October 2022
  41. HARRIS M, Sun J, Keeran K, Aponte A, et al
    Ogfod1 deletion increases cardiac beta-alanine levels and protects mice against ischaemia- reperfusion injury.
    Cardiovasc Res. 2022;118:2847-2858.
    >> Share

    September 2022
  42. NAH J, Shirakabe A, Mukai R, Zhai P, et al
    Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart.
    Cardiovasc Res. 2022;118:2638-2651.
    >> Share

  43. HUBERT F, Payan SM, Pelce E, Bouchard L, et al
    FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis.
    Cardiovasc Res. 2022;118:2625-2637.
    >> Share

  44. LECOUR S, Du Pre BC, Botker HE, Brundel BJJM, et al
    Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart.
    Cardiovasc Res. 2022;118:2566-2581.
    >> Share

  45. LIU T, Meng Z, Liu J, Li J, et al
    Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells.
    Cardiovasc Res. 2022 Sep 5. pii: 6692411. doi: 10.1093.
    >> Share

    August 2022
  46. ANG D, Berry C
    FAVOR III China: quantitative flow ratio-guided coronary intervention in practice.
    Cardiovasc Res. 2022;118:e78-e80.
    >> Share

  47. RIZZO G, Gropper J, Piollet M, Vafadarnejad E, et al
    Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction.
    Cardiovasc Res. 2022 Aug 11. pii: 6660804. doi: 10.1093.
    >> Share

    July 2022
  48. ZHAO T, Mallat Z
    Adapting treatments for adaptive immunity in ischaemic heart disease.
    Cardiovasc Res. 2022;118:e66-e68.
    >> Share

  49. WEI X, Zou S, Xie Z, Wang Z, et al
    EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization.
    Cardiovasc Res. 2022;118:2179-2195.
    >> Share

  50. RIOS R, Miller RJH, Hu LH, Otaki Y, et al
    Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.
    Cardiovasc Res. 2022;118:2152-2164.
    >> Share

    June 2022
  51. CREA F, Liuzzo G
    Attilio Maseri: scientist, clinician, mentor, and gentleman.
    Cardiovasc Res. 2022;118:e57-e58.
    >> Share

  52. HARM T, Bild A, Dittrich K, Goldschmied A, et al
    Acute coronary syndrome is associated with a substantial change in the platelet lipidome.
    Cardiovasc Res. 2022;118:1904-1916.
    >> Share

  53. COUCH LS, Fiedler J, Chick G, Clayton R, et al
    Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure.
    Cardiovasc Res. 2022;118:1758-1770.
    >> Share

  54. OZCAN I, Toya T, Corban MT, Ahmad A, et al
    Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients.
    Cardiovasc Res. 2022;118:1703-1712.
    >> Share

  55. MARGARITIS M, Saini F, Baranowska-Clarke AA, Parsons S, et al
    Vascular histopathology and connective tissue ultrastructure in spontaneous coronary artery dissection: pathophysiological and clinical implications.
    Cardiovasc Res. 2022;118:1835-1848.
    >> Share

    May 2022
  56. HE W, McCarroll CS, Nather K, Ford K, et al
    Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.
    Cardiovasc Res. 2022;118:1535-1547.
    >> Share

    March 2022
  57. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    >> Share

  58. ZENG L, Moser S, Mirza-Schreiber N, Lamina C, et al
    Cis-epistasis at the LPA locus and risk of cardiovascular diseases.
    Cardiovasc Res. 2022;118:1088-1102.
    >> Share

  59. SHAH M, He Z, Rauf A, Beikoghli Kalkhoran S, et al
    Extracellular histones are a target in myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2022;118:1115-1125.
    >> Share

    February 2022
  60. ARIBAS E, Roeters van Lennep JE, Elias-Smale SE, Piek JJ, et al
    Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review.
    Cardiovasc Res. 2022;118:763-771.
    >> Share

    January 2022
  61. DEL CAMPO CV, Liaw NY, Gunadasa-Rohling M, Matthaei M, et al
    Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer.
    Cardiovasc Res. 2022;118:597-611.
    >> Share

  62. KALKHORAN SB, Kriston-Vizi J, Hernandez-Resendiz S, Crespo-Avilan GE, et al
    Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
    Cardiovasc Res. 2022;118:282-294.
    >> Share

  63. ZIETZER A, Steffen E, Niepmann S, Dusing P, et al
    MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease.
    Cardiovasc Res. 2022;118:316-333.
    >> Share

  64. DEHGHANI T, Thai PN, Sodhi H, Ren L, et al
    Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
    Cardiovasc Res. 2022;118:267-281.
    >> Share

    December 2021
  65. PETRIE MC, Jhund PS, Connolly E, Mark PB, et al
    High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis.
    Cardiovasc Res. 2021 Dec 7. pii: 6454738. doi: 10.1093.
    >> Share

    November 2021
  66. OIKONOMOU EK, Antonopoulos AS, Schottlander D, Marwan M, et al
    Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device.
    Cardiovasc Res. 2021;117:2677-2690.
    >> Share

  67. POBER JS, Chih S, Kobashigawa J, Madsen JC, et al
    Cardiac allograft vasculopathy: current review and future research directions.
    Cardiovasc Res. 2021;117:2624-2638.
    >> Share

  68. HEINRICHS M, Ashour D, Siegel J, Buchner L, et al
    The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
    Cardiovasc Res. 2021;117:2664-2676.
    >> Share

  69. WANG Y, Polten F, Jackle F, Korf-Klingebiel M, et al
    A mouse model of cardiogenic shock.
    Cardiovasc Res. 2021;117:2414-2415.
    >> Share

    September 2021
  70. RAVINDRAN D, Karimi Galougahi K, Tan JTM, Kavurma MM, et al
    The multiple roles of chemokines in the mechanisms of stent biocompatibility.
    Cardiovasc Res. 2021;117:2299-2308.
    >> Share

    August 2021
  71. LIBERALE L, Akhmedov A, Vlachogiannis NI, Bonetti NR, et al
    Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system.
    Cardiovasc Res. 2021;117:2275-2288.
    >> Share

    July 2021
  72. YANG H, Shao N, Holmstrom A, Zhao X, et al
    Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue.
    Cardiovasc Res. 2021;117:2125-2136.
    >> Share

  73. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    >> Share

  74. NOSALSKI R, Guzik TJ
    IL-15 and IL-7: keys to dysregulated inflammation in acute coronary syndromes.
    Cardiovasc Res. 2021;117:1806-1808.
    >> Share

  75. THONDAPU V, Mamon C, Poon EKW, Kurihara O, et al
    High spatial endothelial shear stress gradient independently predicts site of acute coronary plaque rupture and erosion.
    Cardiovasc Res. 2021;117:1974-1985.
    >> Share

  76. BULLENKAMP J, Mengoni V, Kaur S, Chhetri I, et al
    Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.
    Cardiovasc Res. 2021;117:1935-1948.
    >> Share

    May 2021
  77. FIGTREE GA, Vernon ST
    Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries.
    Cardiovasc Res. 2021;117:e76-e78.
    >> Share

  78. TAO Z, Loo S, Su L, Tan S, et al
    Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Cardiovasc Res. 2021;117:1578-1591.
    >> Share

  79. MORRIS PD, Gosling R, Zwierzak I, Evans H, et al
    A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease.
    Cardiovasc Res. 2021;117:1567-1577.
    >> Share

    April 2021
  80. PAGANELLI F, Gaudry M, Ruf J, Guieu R, et al
    Recent advances in the role of the adenosinergic system in coronary artery disease.
    Cardiovasc Res. 2021;117:1284-1294.
    >> Share

  81. BOLLI R, Solankhi M, Tang XL, Kahlon A, et al
    Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts.
    Cardiovasc Res. 2021 Apr 19. pii: 6237881. doi: 10.1093.
    >> Share

    March 2021
  82. PRAG HA, Gruszczyk AV, Huang MM, Beach TE, et al
    Mechanism of succinate efflux upon reperfusion of the ischaemic heart.
    Cardiovasc Res. 2021;117:1188-1201.
    >> Share

  83. BUDOFF MJ, Muhlestein JB, Bhatt DL, Le Pa VT, et al
    Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
    Cardiovasc Res. 2021;117:1070-1077.
    >> Share

    February 2021
  84. NAMBU H, Takada S, Maekawa S, Matsumoto J, et al
    Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
    Cardiovasc Res. 2021;117:805-819.
    >> Share

  85. KIZILAY MANCINI O, Huynh DN, Menard L, Shum-Tim D, et al
    Ex vivo Ikkbeta ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis.
    Cardiovasc Res. 2021;117:756-766.
    >> Share

  86. LIANG Y, Zhu J, Liu L, Anand SS, et al
    Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease.
    Cardiovasc Res. 2021;117:942-949.
    >> Share

  87. KOMPA AR, Greening DW, Kong AM, McMillan PJ, et al
    Sustained subcutaneous delivery of secretome of human cardiac stem cells promotes cardiac repair following myocardial infarction.
    Cardiovasc Res. 2021;117:918-929.
    >> Share

  88. DE LUCIA C, Grisanti LA, Borghetti G, Piedepalumbo M, et al
    GRK5 contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.
    Cardiovasc Res. 2021 Feb 9. pii: 6131786. doi: 10.1093.
    >> Share

    January 2021
  89. PERRINO C, Ferdinandy P, Botker HE, Brundel BJJM, et al
    Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.
    Cardiovasc Res. 2021;117:367-385.
    >> Share

  90. KOAY YC, Chen YC, Wali JA, Luk AWS, et al
    Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
    Cardiovasc Res. 2021;117:435-449.
    >> Share

  91. GOROG DA, Farag M, Spinthakis N, Yellon DM, et al
    Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial.
    Cardiovasc Res. 2021;117:623-634.
    >> Share

  92. KUANG Y, Li X, Liu X, Wei L, et al
    Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction.
    Cardiovasc Res. 2021;117:585-599.
    >> Share

  93. ANTIKAINEN AAV, Sandholm N, Tregouet DA, Charmet R, et al
    Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus.
    Cardiovasc Res. 2021;117:600-612.
    >> Share

  94. AMANAKIS G, Sun J, Fergusson MM, McGinty S, et al
    Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
    Cardiovasc Res. 2021;117:212-223.
    >> Share

  95. CORCORAN D, Radjenovic A, Mordi IR, Nazir SA, et al
    Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.
    Cardiovasc Res. 2021;117:320-329.
    >> Share

  96. LIMA CORREA B, El Harane N, Gomez I, Rachid Hocine H, et al
    Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
    Cardiovasc Res. 2021;117:292-307.
    >> Share

  97. NAKASHIMA Y, Sakai Y, Mizuno Y, Furuno K, et al
    Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Cardiovasc Res. 2021;117:96-108.
    >> Share

  98. LI Y, Yan H, Guo J, Han Y, et al
    Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.
    Cardiovasc Res. 2021;117:240-255.
    >> Share

    February 2020
  99. MOLITOR M, Rudi WS, Garlapati V, Finger S, et al
    Nox2+ Myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovasc Res. 2020 Feb 20. pii: 5741408. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016